FDA Breakthrough Therapy designation received for PF614-MPAR ~~ PF614-MPAR second clinical trial initiated ~~ Lead clinical candidate identified for OUD program ~~ PF614 Phase 3 trial poised to ...
President Jim Kalua has expressed satisfaction with the strides the association is making, particularly after investing MK10.4 million in a medical scheme for its members. According to Kalua, the ...
BLANTYRE-(MaraviPost)-The rehabilitation of the Gumulira-Liveya Bridge, a vital infrastructure connecting Chikuli and Mulemba wards in Mulanje South West Constituency, is set to cost over MK100 ...
Rebel forces in Sudan are committing genocide amid a war of “unmitigated brutality” and the world’s largest humanitarian catastrophe, the U.S. government said on January 7.